Trademark: 97533508
Word
CLINIPRIME
Status
Registered
Status Code
700
Status Date
Tuesday, January 9, 2024
Serial Number
97533508
Registration Number
7271459
Registration Date
Tuesday, January 9, 2024
Mark Type
4000
Filing Date
Wednesday, August 3, 2022
Published for Opposition
Tuesday, November 1, 2022

Trademark Owner History
Charles River Laboratories, Inc. - Original Registrant

Classifications
5 Cells for medical or clinical use; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes
1 Biological tissue, namely, bone marrow, cord blood, normal peripheral blood, and mobilized peripheral blood, for use in scientific and medical research; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells for research purposes; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Biological tissue, namely, blood for scientific or medical research use
CLINICAL PRIME

Trademark Events
Jan 9, 2024
Notice Of Registration Confirmation Emailed
Jan 9, 2024
Registered-Principal Register
Dec 6, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 5, 2023
Allowed Principal Register - Sou Accepted
Nov 10, 2023
Teas/Email Correspondence Entered
Nov 10, 2023
Correspondence Received In Law Office
Nov 10, 2023
Teas Response To Office Action Received
Aug 12, 2023
Notification Of Non-Final Action E-Mailed
Aug 12, 2023
Non-Final Action E-Mailed
Aug 12, 2023
Su - Non-Final Action - Written
May 23, 2023
Divisional Request Received
Jul 12, 2023
Statement Of Use Processing Complete
Jun 14, 2023
Use Amendment Filed
Jul 12, 2023
Case Assigned To Intent To Use Paralegal
Jun 14, 2023
Teas Statement Of Use Received
Dec 27, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Published For Opposition
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Sep 26, 2022
Approved For Pub - Principal Register
Sep 24, 2022
Examiner's Amendment Entered
Sep 24, 2022
Notification Of Examiners Amendment E-Mailed
Sep 24, 2022
Examiners Amendment E-Mailed
Sep 24, 2022
Examiners Amendment -Written
Sep 23, 2022
Assigned To Examiner
Aug 25, 2022
New Application Office Supplied Data Entered
Aug 6, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24